By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mustang Bio, Inc. 

2 Gansevoort Street, 9th floor

New York  New York  10014  U.S.A.
Phone: 781-652-4500 Fax: n/a


SEARCH JOBS

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies based on the ground breaking Chimeric Antigen Receptor (CAR) research of Dr. Stephen Forman and Dr. Christine Brown of City of Hope, an NCI-designated Comprehensive Cancer Center. Mustang was formed to help bring this pioneering CAR research to as many patients as possible. Mustang, through a research agreement with COH, will develop CARs across multiple cancers, including for AML and Brain Cancer. Both of the lead programs are in phase I clinical trials.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Manuel Litchman

CFO: David Horin

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@mustangbio.com
Ownership: Private

Web Site: Mustang Bio
Employees:
Symbol: 
 









Company News
//-->